Stimcell Energetics Reports Decreased Losses and Increased Assets for Q3 and Nine-Month Period

Stimcell Energetics Inc. reported its financial results for the three and nine months ended February 28, 2026, revealing a net loss of $90,566 for the third quarter and $665,916 for the nine-month period. This represents a decrease in losses compared to the same periods in the previous fiscal year, where the company recorded a net loss of $140,537 and $346,964, respectively. The reduction in losses is attributed to a significant decrease in total operating expenses, which fell to $71,908 for the third quarter from $131,086 a year earlier, and to $617,308 from $321,420 for the nine-month period.

The company’s total assets increased to $34,521,000 as of February 28, 2026, up from $21,222,000 at the end of the previous fiscal year. This growth was primarily driven by an increase in other current assets, which rose to $24,264,000 from $6,641,000. However, total liabilities also increased significantly, reaching $1,712,941, compared to $1,267,508 in the prior period. The accumulated deficit widened to $11,527,472 from $10,861,556, indicating ongoing challenges in achieving profitability.

In terms of strategic developments, Stimcell Energetics has made notable organizational changes, including the issuance of 750,000 shares valued at $250,000 to an investor relations firm for services rendered. This move is part of the company's efforts to enhance its market presence and investor engagement. The company has also maintained its focus on research and development, with R&D costs amounting to $36,561 for the third quarter, reflecting its commitment to advancing its product offerings.

Operationally, the company has seen fluctuations in its financial metrics, with a weighted average of 20,891,272 shares outstanding as of February 28, 2026. The company’s cash position decreased to $10,257 from $14,581, indicating a tightening liquidity situation. Despite these challenges, management remains optimistic about future growth, emphasizing the need for additional financing to support operations and achieve profitability. The company plans to pursue funding through various means, including borrowing from directors and officers, issuing promissory notes, and private placements of common stock.

Looking ahead, Stimcell Energetics acknowledges the uncertainty surrounding its ability to continue as a going concern, contingent upon securing necessary financing and achieving profitable operations. The company’s management is actively exploring options to stabilize its financial position and enhance its operational capabilities, aiming to navigate the competitive landscape of the biotech industry effectively.